ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Merus NV

Merus NV (2GH)

41.40
0.00
( 0.00% )
Updated: 01:32:04
Realtime Data

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
41.40
Bid
41.00
Ask
41.80
Volume
0.00
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
41.40
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

2GH Latest News

Merus Announces FDA Approval of BIZENGRI® (zenocutuzumab-zbco) for NRG1+ Pancreatic Adenocarcinoma and NRG1+ Non–Small Cell Lung Cancer (NSCLC) Based on Safety and Efficacy Data From the eNRGy Study

Merus Announces FDA Approval of BIZENGRI® (zenocutuzumab-zbco) for NRG1+ Pancreatic Adenocarcinoma and NRG1+ Non–Small Cell Lung Cancer (NSCLC) Based on Safety and Efficacy Data From the eNRGy...

Merus and Partner Therapeutics Announce License Agreement for the U.S. Commercialization of Zenocutuzumab in NRG1 Fusion-Positive Cancer

Merus and Partner Therapeutics Announce License Agreement for the U.S. Commercialization of Zenocutuzumab in NRG1 Fusion-Positive Cancer UTRECHT, The Netherlands and CAMBRIDGE, Mass., Dec. 02...

Merus et Partner Therapeutics annoncent un contrat de licence en vue de la commercialisation aux États-Unis du zenocutuzumab dans le cadre du traitement des cancers à fusion NRG1 positive

Merus et Partner Therapeutics annoncent un contrat de licence en vue de la commercialisation aux États-Unis du zenocutuzumab dans le cadre du traitement des cancers à fusion NRG1 positive UTRECHT...

Merus und Partner Therapeutics geben Lizenzvereinbarung für die Vermarktung von Zenocutuzumab in den USA bei NRG1-fusionspositivem Krebs bekannt

Merus und Partner Therapeutics geben Lizenzvereinbarung für die Vermarktung von Zenocutuzumab in den USA bei NRG1-fusionspositivem Krebs bekannt UTRECHT, Niederlande, und CAMBRIDGE, Massachusetts...

Merus gibt am ESMO-Kongress 2024 in Asien die Veröffentlichung eines Abstracts zur Behandlung von rezidivierenden/metastasierten Kopf- und Halstumoren ab der zweiten Behandlungslinie mit Petosemtamab bekannt

Merus gibt am ESMO-Kongress 2024 in Asien die Veröffentlichung eines Abstracts zur Behandlung von rezidivierenden/metastasierten Kopf- und Halstumoren ab der zweiten Behandlungslinie mit...

Merus annonce la publication d’un résumé sur le pétosemtamab en tant que traitement de 2e ligne et au-delà pour le CETC r/m lors de l’édition 2024 du Congrès de l’ESMO Asia

Merus annonce la publication d’un résumé sur le pétosemtamab en tant que traitement de 2e ligne et au-delà pour le CETC r/m lors de l’édition 2024 du Congrès de l’ESMO Asia – Les données...

Merus Announces Publication of an Abstract on Petosemtamab as 2L+ treatment of r/m HNSCC at the ESMO Asia Congress 2024

Merus Announces Publication of an Abstract on Petosemtamab as 2L+ treatment of r/m HNSCC at the ESMO Asia Congress 2024 – Petosemtamab 1500 mg monotherapy phase 2 interim data continues to...

Merus annonce sa participation aux prochaines journées Investisseurs

Merus annonce sa participation aux prochaines journées Investisseurs UTRECHT, Pays-Bas et CAMBRIDGE, État du Massachusetts, 07 nov. 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq : MRUS), une...

Merus hält Vorträge auf bevorstehenden Investorenkonferenzen

Merus hält Vorträge auf bevorstehenden Investorenkonferenzen UTRECHT, Niederlande und CAMBRIDGE, Massachusetts, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS), ein Unternehmen aus...

La FDA octroie à Merus un report de la date PDUFA pour le zénocutuzumab

La FDA octroie à Merus un report de la date PDUFA pour le zénocutuzumab UTRECHT, Pays-Bas et CAMBRIDGE, Massachusetts, 05 nov. 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq : MRUS), ci-après...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
C62Chariot Limited
0.031 €
(29.17%)
3.5k
A6NAsana Inc
17.50 €
(19.86%)
556
ZJ0Showcase Minerals Inc
0.156 €
(15.56%)
100
DS3DocuSign Inc
90.31 €
(14.06%)
1.96k
EJZNWealth Minerals Ltd
0.0326 €
(13.19%)
30k
XONAExxon Mobil Corp
13.1531 €
(-87.88%)
662
AXIAtos SE
0.0291 €
(-85.26%)
15.29M
42FBAIML Innovations Inc
0.0512 €
(-22.19%)
343
H5EHelma Eigenheimbau Ag
0.0552 €
(-21.14%)
165
IAHInternational Lithium Corp
0.01 €
(-20.00%)
2k
AXIAtos SE
0.0291 €
(-85.26%)
15.29M
POQ88 Energy Limited
0.001 €
(-16.67%)
380k
DBKDeutsche Bank AG
17.018 €
(0.42%)
289.61k
432Arbor Metals Corp
0.18 €
(-5.36%)
204.57k
TUI1Tui AG
8.428 €
(1.44%)
170.23k

Discussion

View Full Feed
oldmystic oldmystic 4 minutes ago
Steady, pardon the late reply.
The short answer is lower premium and higher leverage.
I do not plan to hold to expiration so just a trading vehicle.
AVXL
fade fade 5 minutes ago
I agree, they went from twitter blabber mouths to having over a month gaps in updates
BLFR
manibiotech manibiotech 7 minutes ago
https://clinicaltrials.ucsf.edu/trial/NCT03091660

Again . It's there 
NWBO
Jefedejefes Jefedejefes 17 minutes ago
Time to start a class action lawsuit against current and former officers and directors, who is in? Nothing but hype and BS (lies) over the last year.

EDXC
BeachBum BeachBum 19 minutes ago
Multiple Updates - Cobalt Mining - December 5, 2024:

Breaking: Valiant Eagle's Landmark Deal

Valiant Eagle Inc. (VE) has executed the most significant deal in its history by securing a 50% stake in several mines in the Democratic Republic of Congo (DRC). These mines are
PSRU
BeachBum BeachBum 20 minutes ago
You’ll be chasing or sidelined. PSRU
PSRU
trader53 trader53 20 minutes ago
WCVC - Nixon Restaurant Group


WCVC - Nixon Restaurant Concepts


* Waiting for - https://www.nixonrestaurantgroup.com

* Waiting for - https://westcoastventuresgroupcorp.com


https://investorshub.advfn.com/uicon/155
WCVC
zandant zandant 21 minutes ago
Will anyone ever hear from Ehrlich again?
IPIX
mc73 mc73 22 minutes ago
I think #2 as well. Which is why I sold and moved on. I still watch this as it has a sh!t ton of potential. IDE approval is the only thing this ticker needs to explode. Chances look dim to me but things could turn around 
RDGL
zandant zandant 22 minutes ago
Point your anger over what must be a significant loss at Ehrlich, "dude." Still believing that this garbage is hidden treasure is what's truly sick.
IPIX
BeachBum BeachBum 26 minutes ago
$100 for 1 million shares in a cobalt mine with a note owing from BELR for $500k that bids at $5.00. This should be .005+. I’m gonna be rich because I can’t sell and you people are stupid for not buying this. I took a few mil off the ask and will add. Already have an insane amount.
PSRU
powerbattles powerbattles 26 minutes ago
James does not own any restricted shares, and no one else does either. The company only has one class of shares: common shares. Whoever holds the most common shares is the key focus, and that's where the story will unfold.
AFFU
trader53 trader53 28 minutes ago
WCVC - Nixon Restaurant Concepts


https://investorshub.advfn.com/uicon/155361.png?cb=636663556275030000

https://investorshub.advfn.com/uimage/uploads/2024/12/6/mnyogDetective.jpg

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=1754
WCVC
Vexari Vexari 34 minutes ago
Branch out

To the humanity level

So that it can be

Understood
IronPantz IronPantz 37 minutes ago
I've been watching ASII for a while. HMBL set a OTC trading record today with 2.2 billion shares traded.
ASII HMBL
vvinvestorshub_free vvinvestorshub_free 38 minutes ago
Test msg +😮  2
vvinvestorshub_pro vvinvestorshub_pro 39 minutes ago
Test +👌
vvinvestorshub_pro vvinvestorshub_pro 39 minutes ago
Test
vvinvestorshub_free vvinvestorshub_free 40 minutes ago
Test msg +😮
powerbattles powerbattles 43 minutes ago
Yes, I need PPS of 0.00263. This should be easily achievable in one day if the merger is announced. I'm disappointed that Jim is handling things, as I'm not too fond of his approach. I was always excited about the merger because the new sheriff would bring a fresh perspective.
AFFU
ducci1 ducci1 49 minutes ago
Pivot Calcs: SPX Pivot--6080----R1--6088----R2--6102----S1--6066----S2--6058-----SPY Pivot--606----R1--607----R2--608----S1--605----S2--604-----VIX Pivot--13.62 !!LOL!!
SPY
PatentGuy1 PatentGuy1 50 minutes ago
Yes Apple invested $20 million, but put it into perspective. The $20 million Apple invested was change found in Apple’s figurative couch - chump change. Apple reportedly spent $10 Billion on project Titan, and walked away from EV. If/when Apple walks away from Liquidmetal, no one at Apple is goin
LQMT
eur06 eur06 53 minutes ago
I agree dino, regardless of this type of price action it’s a buy for me also.
VCNX
VCNX

Your Recent History

Delayed Upgrade Clock